GCM Grosvenor
GCMG
13.20
+0.23
+1.77%
GCM Grosvenor
US · GCMG
#3427 by market cap
Listed 2020
13.20
+0.23
+1.77%
Live - 5344 symbols - heartbeat 147s ago
· 2026-10-09 19:30
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.40, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +8.47% YoY
Margins
- Operating margin
- 26.47%
- Net margin
- 8.02%
Key ratios & quality
- PEG ratioi
- 0.80
- Altman Z-Scorei
- 2.40
PEG uses trailing P/E against the 3-year net income growth rate (31.79%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 378.50M | 416.39M | 429.98M | 531.59M | 446.53M | 445.00M | 514.01M | 557.57M |
| Gross profit | 179.21M | 173.44M | 44.67M | 243.73M | -- | -- | -- | -- |
| Selling & admin expenses | 92.96M | 88.46M | 84.63M | 88.35M | 366.22M | 456.85M | 440.53M | 424.11M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 92.09M | 92.49M | -32.37M | 161.90M | 90.42M | -206.00K | 89.07M | 149.71M |
| Pretax profit | 65.08M | 62.32M | -78.70M | 153.06M | 89.09M | -21.51M | 50.16M | 154.94M |
| Tax | 1.40M | 2.32M | 4.51M | 10.99M | 9.61M | 7.69M | 13.56M | 12.90M |
| Net profit | 63.69M | 60.00M | -83.20M | 142.07M | 79.48M | -29.21M | 36.60M | 142.04M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Diluted EPS | 0.00 | 0.00 | -2.62 | 0.28 | 0.28 | -0.28 | 0.03 | 0.42 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 125.85M | 119.66M | 134.97M | 177.10M | 124.78M | 134.34M |
| Gross profit | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | 110.52M | 100.41M | 90.79M | 122.39M | 104.30M | 98.85M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 16.09M | 25.03M | 51.46M | 57.13M | 24.40M | 38.96M |
| Pretax profit | 2.50M | 39.69M | 48.71M | 64.05M | 20.88M | 35.54M |
| Tax | 3.59M | -202.00K | 3.62M | 5.89M | 3.14M | 3.69M |
| Net profit | -1.09M | 39.89M | 45.08M | 58.16M | 17.74M | 31.85M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.02 | 0.05 | 0.16 | 0.19 | 0.06 | 0.12 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | -- | 124.76M | 293.42M | 221.26M | 133.48M | 110.30M | 188.87M | 354.52M |
| Cash & ST investments | -- | 79.87M | 198.15M | 96.19M | 85.16M | 44.35M | 89.45M | 242.12M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | -- | 373.16M | 632.28M | 581.62M | 488.93M | 504.94M | 612.73M | 813.76M |
| Total current liabilities | -- | 41.87M | 73.67M | 69.36M | 64.59M | 62.89M | 61.53M | 64.74M |
| Short-term debt | -- | 25.00M | -- | -- | -- | -- | -- | -- |
| Long-term debt | -- | 423.50M | 335.16M | 390.52M | 387.63M | 384.73M | 432.04M | 428.44M |
| Total liabilities | -- | 586,986,000.00 | 599,347,000.00 | 637,425,000.00 | 582,939,000.00 | 616,172,000.00 | 703,070,000.00 | 686,330,000.00 |
| Total equity | -- | -213.83M | 32.93M | -55.80M | -94.01M | -111.23M | -90.34M | 127.43M |
| Retained earnings | -- | -308.44M | -29.83M | -26.22M | -23.93M | -32.22M | -35.04M | -16.26M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 157.42M | 193.92M | 238.81M | 354.52M | 222.11M | 206.80M |
| Cash & ST investments | 94.50M | 136.33M | 182.75M | 242.12M | 164.39M | 139.60M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 579.82M | 636.86M | 685.93M | 813.76M | 688.78M | 677.05M |
| Total current liabilities | 90.46M | 101.63M | 104.58M | 64.74M | 97.21M | 87.02M |
| Short-term debt | -- | -- | -- | -- | -- | -- |
| Long-term debt | 431.14M | 430.24M | 429.34M | 428.44M | 362.93M | 362.00M |
| Total liabilities | 669,492,000.00 | 657,498,000.00 | 682,110,000.00 | 686,330,000.00 | 566,495,000.00 | 554,648,000.00 |
| Total equity | -89.67M | -20.64M | 3.82M | 127.43M | 122.28M | 122.40M |
| Retained earnings | -40.68M | -31.31M | -27.23M | -16.26M | -19.44M | -18.14M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 117.03M | 96.19M | 68.17M | 178.80M | 216.51M | 92.07M | 148.77M | 183.54M |
| Depreciation & amortization | 11.66M | 10.34M | 9.82M | 4.02M | 3.86M | 2.70M | 3.32M | 4.42M |
| Free cash flow | 116.16M | 92.20M | 66.86M | 178.23M | 215.73M | 88.30M | 132.05M | 175.04M |
| Dividends paid | -- | 0 | 0 | -14.53M | -18.43M | -20.32M | -20.55M | -25.34M |
| Stock buybacks / issuance | -- | 0 | 0 | -887.00K | -26.39M | -4.48M | 0 | 19.18M |
| Ending cash balance | 68.10M | 79.87M | 198.15M | 96.19M | 85.16M | 44.35M | 89.45M | 242.12M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 33.26M | 41.98M | 79.82M | 28.48M | 51.72M | 38.12M |
| Depreciation & amortization | 1.01M | 1.15M | 1.16M | 1.10M | 920.00K | 1.03M |
| Free cash flow | 32.09M | 40.76M | 78.27M | 23.92M | 47.88M | 36.26M |
| Dividends paid | -5.07M | -7.00M | -5.91M | -7.37M | -7.51M | -9.23M |
| Stock buybacks / issuance | 0 | 49.83M | 0 | -30.66M | -17.47M | -2.19M |
| Ending cash balance | 94.50M | 136.33M | 182.75M | 242.12M | 164.39M | 139.60M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- | -- | -- |
| ROA %i | -- | 0.00 | 1.49 | 3.54 | 3.70 | 2.57 | 3.35 | 6.36 |
| ROIC %i | -- | -- | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 23.50 | 21.13 | -9.16 | 29.98 | 24.84 | 0.49 | 14.20 | 31.43 |
| FCF / sales %i | 29.81 | 22.14 | 15.44 | 30.86 | 47.67 | 19.54 | 25.22 | 30.95 |
| Current ratioi | -- | 2.98 | 3.98 | 3.19 | 2.07 | 1.75 | 3.07 | 5.48 |
| Quick ratioi | -- | 2.98 | 3.98 | 3.19 | 2.07 | 1.75 | 3.07 | 5.48 |
| Debt / assetsi | -- | 120.19 | 53.01 | 67.14 | 82.45 | 84.41 | 79.30 | 59.01 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- | -- | 1,779.15 |
| Interest coveragei | 3.46 | 3.43 | -1.69 | 8.62 | 4.82 | 0.09 | 3.08 | 7.80 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 14.02 | 2.81 | 1.43 | -3.22 | 7.72 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | 46.67 | -4.53 | 31.79 |
| FCF CAGR (3Y) %i | -- | -- | -- | 15.34 | 32.76 | 9.71 | -9.51 | -6.73 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | 682.08 |
| ROA %i | 3.16 | 4.69 | 5.39 | 6.36 | 7.94 | 6.77 |
| ROIC %i | -- | -- | -- | -- | -- | 13.86 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 17.57 | 21.63 | 27.00 | 31.43 | 34.43 | 32.76 |
| FCF / sales %i | 26.84 | 31.65 | 33.72 | 30.95 | 33.64 | 32.18 |
| Current ratioi | 1.74 | 1.91 | 2.28 | 5.48 | 2.28 | 2.38 |
| Quick ratioi | 1.74 | 1.91 | 2.28 | 5.48 | 2.28 | 2.38 |
| Debt / assetsi | 83.48 | 75.97 | 70.20 | 59.01 | 60.17 | 60.99 |
| LT debt / equityi | -- | -- | -- | 1,779.15 | 1,625.87 | 1,629.73 |
| Interest coveragei | 3.95 | 4.97 | 6.46 | 7.80 | 8.88 | 9.25 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-09 19:30:06 · For reference only, not investment advice and not tailored to your situation.
GCM Grosvenor discussion 0 comments